HAP Trading’s Acorda Therapeutics ACOR Stock Holding History

HAP Trading’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-291	Closed	-$1.02M	–	1445
2013 Q4	$1.02M	Buy	+291	New	+$1.13M	0.03%	423

Other funds holding ACOR

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

HAP Trading's ACOR Position: Q1 2014 in Review

HAP Trading sold out of Acorda Therapeutics (ACOR) in Q1 2014, closing a stake of 291 shares — an estimated $1.02M sold.

HAP Trading first reported a position in ACOR in Q4 2013 and held it in 1 quarter. The position peaked at $1.02M in Q4 2013. 152 funds tracked by Wall St. Rank hold ACOR as of Q1 2014.

HAP Trading reported no remaining Acorda Therapeutics position as of Q1 2014 after selling out during the quarter.
HAP Trading sold 291 Acorda Therapeutics shares in Q1 2014, an estimated $1.02M.
HAP Trading first reported a position in Acorda Therapeutics in Q4 2013 and held it in 1 quarter.
HAP Trading's Acorda Therapeutics position peaked at $1.02M in Q4 2013.
152 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2014.

Based on HAP Trading's 13F filing for Q1 2014, filed 12 May 2014.